Flow injection analysis of doxazosin mesylate using UV-detection

被引:16
作者
Altiokka, G [1 ]
Atkosar, Z [1 ]
机构
[1] Anadolu Univ, Fac Pharm, Dept Analyt Chem, TR-26470 Eskisehir, Turkey
关键词
determination of doxazosin mesylate; flow injection analysis; pharmaceutical application;
D O I
10.1016/S0731-7085(01)00516-7
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A flow injection analysis (FIA) of doxazosin mesylate (DOX) using UV detection is described in this study. The best solvent system was found to be consisting of 0.1 mol l(-1) acetate buffer at pH 4 having 10%MeOH. A flow rate of 1 ml min(-1) was pumped and active material was detected at 365 nm. The calibration equation was linear in the range of 1.3 x 10(-5) to 6.4 x 10(-5) mol l(-1). Limit of detection and limit of quantitation were calculated to be 1.6 x 10(-6) and 4 x 10(-6) mol l(-1) with a RSD 1.27 and 1.16% (n = 8), respectively. The proposed method was applied to the determination of DOX in the pharmaceutical preparations. The results were compared with those obtained from UV-Spectrophotometry. The results showed that there is a good agreement between FIA method and UV-Spectrophotometry. The validation studies were realised by the related applications and the results were evaluated statistically. According to the results, insignificant difference was observed between the methods. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:841 / 844
页数:4
相关论文
共 15 条
  • [1] Spectrophotometric determination of cefadroxil in drug formulations using flow injection analysis
    Al-Momani, IF
    Awni, I
    Khalil, HS
    Esmadi, F
    [J]. ANALYTICAL LETTERS, 1999, 32 (15) : 2977 - 2988
  • [2] THE ALPHA-1-ADRENOCEPTOR ANTAGONIST PROFILE OF DOXAZOSIN - PRECLINICAL PHARMACOLOGY
    ALABASTER, VA
    DAVEY, MJ
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 : S9 - S17
  • [3] Chiral bioanalysis by normal phase high-performance liquid chromatography-atmospheric pressure ionization tandem mass spectrometry
    AlebicKolbah, T
    Zavitsanos, AP
    [J]. JOURNAL OF CHROMATOGRAPHY A, 1997, 759 (1-2) : 65 - 77
  • [4] Altiokka G, 1997, PHARMAZIE, V52, P879
  • [5] Cathodic stripping voltammetric determination of doxazosin in urine and pharmaceutical tablets using carbon paste electrodes
    Arranz, A
    deBetono, SF
    Moreda, JM
    Cid, A
    Arranz, JF
    [J]. ANALYST, 1997, 122 (08) : 849 - 854
  • [6] Preconcentration and voltammetric determination of the antihypertensive doxazosin on a C8 modified carbon paste electrode
    Arranz, A
    Moreda, JM
    Arranz, JF
    [J]. MIKROCHIMICA ACTA, 2000, 134 (1-2) : 69 - 75
  • [7] DOXAZOSIN IN PATIENTS WITH HYPERTENSION
    CONRAD, KA
    FAGAN, TC
    MACKIE, MJ
    MAYSHAR, PV
    LEE, S
    SOUHRADA, JF
    FALKNER, FC
    LAZAR, JD
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 35 (01) : 21 - 24
  • [8] DOXAZOSIN DETERMINATION BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY USING FLUORESCENCE DETECTION
    COWLISHAW, MG
    SHARMAN, JR
    [J]. JOURNAL OF CHROMATOGRAPHY, 1985, 344 (NOV): : 403 - 407
  • [9] CLINICAL-PHARMACOLOGY OF DOXAZOSIN IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    CUBEDDU, LX
    FUENMAYOR, N
    CAPLAN, N
    FERRY, D
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (04) : 439 - 449
  • [10] UV-Spectrophotometry and square wave voltammetry at nafion-modified carbon-paste electrode for the determination of doxazosin in urine and formulations
    de Betoño, SF
    Garcia, AA
    Valentín, JFA
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 20 (04) : 621 - 630